University of Nebraska - Lincoln

DigitalCommons@University of Nebraska - Lincoln
Biochemistry -- Faculty Publications

Biochemistry, Department of

2016

Endoplasmic Reticulum-associated Degradation of Pca1p, a
Polytopic Protein, via Interaction with the Proteasome at the
Membrane
Nathan Smith
University of Nebraska-Lincoln

David J. Adle
University of Nebraska-Lincoln

Miaoyun Zhao
University of Nebraska-Lincoln

Xiaojuan Qin
University of Nebraska-Lincoln

Heejeong Kim
University of Nebraska-Lincoln, hkim7@unl.edu

See next page for additional authors
Follow this and additional works at: https://digitalcommons.unl.edu/biochemfacpub
Part of the Biochemistry Commons, Biotechnology Commons, and the Other Biochemistry, Biophysics,
and Structural Biology Commons

Smith, Nathan; Adle, David J.; Zhao, Miaoyun; Qin, Xiaojuan; Kim, Heejeong; and Lee, Jaekwon,
"Endoplasmic Reticulum-associated Degradation of Pca1p, a Polytopic Protein, via Interaction with the
Proteasome at the Membrane" (2016). Biochemistry -- Faculty Publications. 196.
https://digitalcommons.unl.edu/biochemfacpub/196

This Article is brought to you for free and open access by the Biochemistry, Department of at
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Biochemistry -- Faculty
Publications by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln.

Authors
Nathan Smith, David J. Adle, Miaoyun Zhao, Xiaojuan Qin, Heejeong Kim, and Jaekwon Lee

This article is available at DigitalCommons@University of Nebraska - Lincoln: https://digitalcommons.unl.edu/
biochemfacpub/196

crossmark
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 291, NO. 29, pp. 15082–15092, July 15, 2016
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A.

Endoplasmic Reticulum-associated Degradation of Pca1p, a
Polytopic Protein, via Interaction with the Proteasome at the
Membrane*
Received for publication, March 7, 2016, and in revised form, May 3, 2016 Published, JBC Papers in Press, May 12, 2016, DOI 10.1074/jbc.M116.726265

Nathan Smith‡, David J. Adle‡, Miaoyun Zhao‡, Xiaojuan Qin‡§, Heejeong Kim‡, and Jaekwon Lee‡1
From the ‡Department of Biochemistry and Redox Biology Center, University of Nebraska, Lincoln, Nebraska, 68588-0664 and the
§
College of Life and Environmental Sciences, Shanghai Normal University, Shanghai, China 200234
Endoplasmic reticulum-associated degradation (ERAD) plays
a critical role in the destruction of terminally misfolded proteins
at the secretory pathway. The system also regulates expression
levels of several proteins such as Pca1p, a cadmium exporter in
yeast. To gain better insight into the mechanisms underlying
ERAD of Pca1p and other polytopic proteins by the proteasome
in the cytosol, our study determined the roles for the molecular
factors of ERAD in dislodging Pca1p from the endoplasmic
reticulum (ER). Inactivation of the 20S proteasome leads to
accumulation of ubiquitinated Pca1p in the ER membrane, suggesting a role for the proteasome in extraction of Pca1p from the
ER. Pca1p formed a complex with the proteasome at the membrane in a Doa10p E3 ligase-dependent manner. Cdc48p is
required for recruiting the proteasome to Pca1p. Although the
Ufd2p E4 ubiquitin chain extension enzyme is involved in efficient degradation of Pca1p, Ufd2p-deficient cells did not affect
the formation of a complex between Pca1p and the proteasome.
Two other polytopic membrane proteins undergoing ERAD,
Ste6*p and Hmg2p, also displayed the same outcomes observed
for Pca1p. However, poly-ubiquitinated Cpy1*p, a luminal
ERAD substrate, was detected in the cytosol independent of proteolytic activities of the proteasome. These results indicate that
extraction and degradation of polytopic membrane proteins at
the ER is a coupled event. This mechanism would relieve the cost
of exposed hydrophobic domains in the cytosol during ERAD.

Buildup of misfolded proteins in the endoplasmic reticulum
(ER)2 induces the unfolded protein response to enhance folding
capacity and reduce new protein synthesis (1– 4). Terminally
misfolded proteins at the secretory pathway are targeted to the
ubiquitin-proteasome-dependent removal system, which is
known as ER-associated degradation (ERAD) (3, 5–9). Accumulation of misfolded proteins or excess turnover is attributed
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to multiple diseases, such as cystic fibrosis, diabetes, and amyotrophic lateral sclerosis as well as Alzheimer and Parkinson
diseases (3, 6, 7).
Several molecular factors involved in ERAD have been characterized (10 –13). In the yeast Saccharomyces cerevisiae, misfolded ER luminal proteins and proteins carrying misfolding(s)
at the transmembrane region(s) are ubiquitinated by the E3
ubiquitin ligase Hrd1p, whereas proteins carrying misfolding(s)
at the cytosolic region(s) are ubiquitinated by Doa10p.
Although these E3 enzymes display substrate specificity, some
overlap has also been observed (14 –17). In congress with the E3
ubiquitin ligases, several other components, such as E2 ubiquitin-conjugating enzymes, E4 ubiquitin extension enzymes, and
molecular chaperones, work for recognition and direction of
substrates to ubiquitin ligases and the proteasome (3, 13, 16).
Because the proteasome is in the cytosol, ERAD substrates
must be mobilized from the ER lumen or dislodged from the
membrane to be destroyed (18). The Cdc48p AAA-ATPase
(p97 in mammals) is thought to provide a primary driving force
in the process (10, 14, 19). It has been proposed that translocation of luminal ERAD substrates to the cytosol may occur
through a translocon (translocation channel) formed with
several proteins, such as Sec61p (20 –28), and E3 ubiquitin
ligases possessing multitransmembrane domains (e.g. Hrd1p)
(29 –31). E4 ubiquitin chain extension enzymes (e.g. Ufd2p
and Hul5p) facilitate ERAD through poly-ubiquitination (10,
32, 33).
Despite significant progress in the identification and characterization of molecular factors involved in ERAD, the mechanisms of how proteins in the ER are targeted to the cytoplasmic
proteasome remained to be elucidated (3, 10, 32). Integral
membrane proteins might be dislodged from the membrane
and escorted to the proteasome for destruction (10), which
requires the cells to extract proteins containing hydrophobic
regions and maintain their solubility in the cytosol. Thus, direct
loading of full-length substrates or fragmented pieces into the
proteasome during extraction from the membrane could be a
mechanism resolving the problem (32).
Our previous study showed that expression of the Pca1p cadmium efflux transporter in the yeast S. cerevisiae is dependent
upon the ERAD pathway (34). In the absence of cadmium,
Pca1p is rapidly turned over through a Doa10p- and proteasomedependent mechanism. However, when cadmium is present,
Pca1p escapes from ERAD and is secreted to the plasma membrane to export cadmium (34, 35). A degron at the N-terminal
VOLUME 291 • NUMBER 29 • JULY 15, 2016
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cytosolic domain is responsible for the ERAD of Pca1p and also
senses cadmium to rescue Pca1p from ERAD. Because of its
rapid turnover (t1⁄2 ⬍ 5 min) (34), a degron- rather than misfolding-dependent ERAD, and control of this process by cadmium, Pca1p is a unique example among ERAD substrates.
Moreover, the well established experimental systems in yeast
and conserved mechanisms for ERAD between yeast and mammals allow Pca1p to be a useful model substrate for gaining a
better understanding of the mechanisms underlying ERAD of
polytopic membrane proteins.
Here we characterized the roles for the molecular factors
involved in dislodging Pca1p from the ER for ERAD. Subcellular location, physical interaction with the proteasome, and
turnover rates of Pca1p were determined in yeast cells using
genetic and biochemical approaches. Our data indicate that
extraction and degradation of Pca1p and two other polytopic
membrane proteins, Ste6*p and Hmg2p, are coordinated by
complex formation with the proteasome while they reside at
the ER membrane. The mechanism is likely significant for
avoiding the release of membrane proteins to the cytosol.

Experimental Procedures
Yeast Strains and Growth Conditions—A BY4741 haploid
S. cerevisiae strain (MATa his3_1, leu2_0, met15_0, and
ura3_0) and null mutants of particular gene(s), including
hul5::KanMX6 (hul5⌬), ufd2::KanMX6 (ufd2⌬), rpn5::
KanMX6 (rpn5⌬), and doa10::KanMX6 (doa10⌬), were
obtained from OpenBiosystems. A pdr5::KanMX6 (pdr5⌬)
strain background was used for experiments in which cells were
co-cultured with cycloheximide, MG132, or bortezomib.
Strains of doa10::His3 or ufd2::His3 in the pdr5⌬ background
were generated by homologous recombination of a deletion
cassette as described previously (36).
Yeast cells were cultured in synthetic complete medium (2%
(v/v) dextrose, 0.2% (v/v) amino acid mixture, and 0.67% (v/v)
yeast nitrogen base) lacking specific amino acid(s) when plasmid selection was necessary. Cells were cultured at 30 °C unless
specified otherwise. To inactivate Cdc48p and Cim3p, strains
expressing a temperature-sensitive CDC48 (cdc48 –3) or CIM3
(cim3–1) allele were cultured at a permissive temperature
(23 °C) and then shifted to a restrictive temperature (37 °C) for
30 min (37, 38).
To inhibit translation, cells at mid-log phase were co-cultured with cycloheximide (Sigma, 100 g/ml) for a period as
indicated in each experiment. To inhibit the proteasome, cells
were co-cultured with MG132 (Cayman Chemical, 20 M) (39)
or bortezomib (Selleck Chemicals, 20 M) (40) for 2 h.
Plasmid Construction—A single-copy yeast vector, p416GPD (41), was used for glyceradehyde-3-phosphate dehydrogenase gene promoter-mediated constitutive expression of PCA1,
N-terminal truncated PCA1 (35), CPY1*, STE6*, and HMG2.
Plasmids for HA epitope tagging and GFP fusion at the N terminus of Pca1p were conducted as described previously (35).
C-terminal c-myc epitope tagging of Pca1p was achieved by
PCR cloning using a primer containing a c-myc sequence prior
to the stop codon. Cpy1*p possesses the G255R substitution to
be targeted to ERAD (13). Site-directed mutagenesis was
accomplished by a primer overlap extension method (42). Two
JULY 15, 2016 • VOLUME 291 • NUMBER 29

c-myc epitopes were inserted in the C terminus of CPY1* for
Western blotting analysis using anti-myc antibodies. HMG2
containing one c-myc epitope (43) was subcloned in the p416GPD vector. Common molecular biology techniques, including
plasmid amplification using Escherichia coli and purification,
followed methods established previously (46). Plasmid transformation into yeast was performed using the lithium acetate
method (44).
Fluorescence Microscopy—Cells cultured in synthetic complete medium were mixed with PBS containing NaN3 (15 mM)
and NaF (15 mM) to inactivate cells. Cells were collected by
centrifugation and subjected to confocal microscopy (Olympus
FV500) as described previously (35).
Fractionation of Cell Lysates—Yeast cells were broken by vortexing (1 min, five times) with glass beads in PBS lysis buffer
containing 1 mM PMSF, 5 mM EDTA, and 50 mM protease
inhibitor mixture (HaltTM, Thermo Scientific). Centrifugation
(4 °C, 1000 ⫻ g, 10 min) removed large cell debris and unbroken
cells. Soluble and membrane-associated proteins were separated by centrifugation (4 °C, 100,000 ⫻ g, 1 h).
To differentiate membrane association versus membrane
integration of Pca1p, membrane fractions of prd5⌬, cdc48 –3
(cultured at 37 °C), and doa10⌬ cells expressing 3HA epitopetagged Pca1p were resolubilized in PBS with and without
Na2CO3 or Triton X-100. After incubation at 4 °C for 30 min,
samples were fractionated by centrifugation (4 °C, 100,000 ⫻ g,
30 min). Supernatant (S) was precipitated using TCA and denatured in SDS sample buffer. The unsoluble pellet (N) was denatured in SDS sample buffer. Both S and N samples were subjected to Western blotting analysis.
Flotation sucrose gradient fractionation was performed as
described previously (45). Yeast cells were broken using glass
beads in lysis buffer (50 mM HEPES, 150 mM NaCl, 5 mM EDTA,
1 mM DTT, 1 mM PMSF, 50 mM protease inhibitor mixture).
Sucrose gradient (0.25 M, 1.5 M, ⬃1.7 M (mixture of 200 l of cell
lysate and 600 l of 2.3 M sucrose), and 2.3 M in descending
order) was spun at 4 °C at 100,000 ⫻ g for 5 h. Twelve fractions
(300 l each) were then taken from the top.
In Vitro Deubiquitination—The flotation sucrose gradient
fractions (10 –12) were subjected to buffer exchange using a
Slide-A-Lyzer dialysis cassette (Thermo Scientific) in 500 ml of
deubiquitination buffer (50 mM HEPES, 150 mM NaCl, 5 mM
EDTA, 1 mM DTT, 1 mM PMSF, and protease inhibitor mixture
without sucrose), followed by incubation with 5 ng of USP2
catalytic domain (BML-UW9850-0100, Enzo Life Sciences)
while rocking at 37 °C for 1 h. Samples were then subjected
to a second round of buffer exchange in the same buffer without DTT. Immunoprecipitation was conducted using a kit
(ProfoundTM c-Myc tag IP/co-IP application set, Thermo Scientific) according to the specifications of the manufacturer.
In Vivo Cross-linking and Immunoprecipitation—Cells expressing Pca1p tagged with the HA epitope were co-cultured
with a 20S proteasome inhibitor, MG132 (20 M, 2 h). Cells
were collected by washing twice in ice-cold PBS and resuspended in PBS containing MG132 and a membrane-permeable
thiol-reversible cross-linker, dimethyl 3,3⬘-dithiobispropionimidate (DTBP) (100 g/ml final concentration), for 30 min
at room temperature with gentle rocking. Cells were then
JOURNAL OF BIOLOGICAL CHEMISTRY
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washed in lysis buffer (50 mM Tris-HCl (pH 7.4), 5 mM EDTA,
50 mM protease inhibitor mixture, and 1 mM PMSF) to quench
the cross-linking reaction. Cells were then broken by glass bead
disruption (10 ⫻ 1 min on ice). Lysates were collected and fractionated by centrifugation (100,000 ⫻ g, 30 min). The resulting
pellet was washed twice in ice-cold PBS and resuspended in PBS
containing Triton X-100 (1%, v/v) and protease inhibitors.
Immunoprecipitation was performed using a kit (ProfoundTM
c-Myc tag IP/co-IP application set, Thermo Scientific) according to the specifications of the manufacturer. DTT in the SDS
sample buffer cleaved the cross-links.
Immunoblotting—Yeast cells were broken by vortexing (5 ⫻
1 min) with glass beads in lysis buffer (PBS containing 1 mM
PMSF, 50 mM protease inhibitor mixture, 5 mM EDTA, and 1%
Triton X-100). The soluble fraction was obtained by centrifugation (21,000 ⫻ g, 15 min). Protein concentrations were measured using a kit (BCA, Pierce) according to the specifications
of the manufacturer. Samples were denatured in a reducing
SDS sample buffer containing DTT (25 mM) for 15 min at 37 °C
and then subjected to PAGE. This mild denaturation condition
avoided aggregation of Pca1p, which contains eight predicted
transmembrane helices. The gels were transferred to a nitrocellulose membrane and hybridized with primary antibodies
against the HA epitope (Rockland, 600-401-384), the Rpn5p
subunit of the 19S proteasome (Abnova, PAB 15594), the ␣ and
␤ subunits of the 20S proteasome (Abcom, ab22673), the c-myc
epitope (ABM, G019), or ubiquitin (Covance, MMS-257P).
3-Phosphoglycerate kinase (Pgk1p) was detected using antiPgk1p antibodies (Invitrogen, 459250) to determine equal loading. Horseradish peroxidase-conjugated goat anti-rabbit IgG
and sheep anti-mouse IgG (Santa Cruz Biotechnology Inc.)
were used as secondary antibodies. Western Pico chemiluminescence (Pierce) was used to detect antibody-bound proteins.
Statistical Analysis—Experiments were conducted using a
minimum of two independent clones, and representative data
are shown. Results are presented as mean ⫾ S.D. Student’s t test
determined the statistical differences. p ⬍ 0.05 was considered
to be significant.

Results
Pca1p Remains in the Membrane When the Proteasome Is
Inactivated—Pca1p, a cadmium-exporting P1B-type ATPase in
yeast, is a polytopic protein (Fig. 1A) that undergoes ERAD in
the absence of cadmium (34). A degron identified within amino
acids 250 and 350 at the N-terminal cytosolic domain (1–557
amino acids, ⬃61 kDa) (Fig. 1A), Doa10p, an E3 ligase, and the
proteasome are required for Pca1p turnover (35). Given the
cadmium-induced rescue of Pca1p from ERAD (34, 35) and its
eight predicted transmembrane helices, we sought to determine whether ERAD of Pca1p relies on known molecular factors for ERAD of misfolded proteins and how this polytopic
protein is degraded by the proteasome. To determine the subcellular localization and turnover rates of Pca1p, we fused GFP
or an epitope, such as triple hemagglutinin (3HA) and two
c-myc (2Myc) at the N or C terminus (Fig. 1A). These PCA1
alleles are fully functional and display cadmium-dependent
ERAD (data not shown).
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We first determined the subcellular distribution of GFPPca1p when proteolytic activities of the proteasome are inhibited by MG132 co-culture (39) or when Cdc48p AAA-ATPase
is inactivated (Fig. 1B). Cdc48p is a known critical player in
dislodging ERAD substrates from the ER (47). A strain possessing a temperature-sensitive CDC48 allele (cdc48 –3) was used
to inactive this essential gene (37) at a restrictive temperature,
37 °C. Cells were precultured with cycloheximide to inhibit new
Pca1p synthesis. Pca1p fused with GFP at the N terminus (GFPPca1p) is not detectable in WT control cells because of rapid
turnover, as demonstrated previously (35). However, Pca1p is
highly expressed when the proteasome or Cdc48p is inactivated
(Fig. 1B). Co-localization of Pca1p-GFP with Sec63p, an ERresident protein, indicates that Pca1p remains in the ER membrane under the experimental conditions. These results suggest
that ubiquitinated Pca1p cannot be extracted from the ER
membrane without proteolytic activities of the proteasome or
upon inactivation of Cdc48p AAA-type ATPase.
We next ascertained the cellular levels of Pca1p and its fragments when the proteasome or Cdc48p is inactivated. Pca1p
fused with 3HA and 2Myc (Fig. 1A) was expressed in WT,
cdc48 –3, and doa10⌬ cells. Western blotting analyses of cell
lysates using anti-HA or c-myc antibodies displayed signals at
the locations corresponding to full-length Pca1p (Fig. 1C,
arrowheads). Given that the half-life of Pca1p is less than 5 min
(35), the majority of remaining Pca1p in WT cells co-cultured
with cycloheximide should be ubiquitinated species. Pca1p
fragments below full-length Pca1p, including ⬃60-, 70-, 75-,
and 90-kDa bands, were detected in WT, cdc48 –3, and doa10⌬
cells (Fig. 1C, top panel). We previously reported that Pca1p
ubiquitination is absent in doa10⌬ cells (34, 35). Therefore,
fragmentation of Pca1p, observed in doa10⌬ cells, is not likely
to be a ubiquitination-dependent process. When probing with
anti-myc antibodies, only full length was detectable, and all
lower molecular weight fragments were nonspecific, as seen by
the empty vector control (Fig. 1C, center panel, first lane). To
determine the distribution of Pca1p, total cell lysates were fractionated by ultracentrifugation (100,000 ⫻ g for 30 min) to
supernatant (S) and pellet (P) containing soluble proteins and
membranes, respectively (Fig. 1D). Western blotting analysis
detected full-length and higher molecular weight Pca1p species
at the P fraction but not the S fraction (Fig. 1D). Immunoprecipitation of Pca1p from the S and P fractions with anti-HA
antibodies followed by Western blotting using anti-HA and
anti-ubiquitin (Ub) antibodies (Fig. 1E) further suggested that
most ubiquitinated Pca1p species, except a portion of the ⬃75kDa fragment, reside in the membrane.
To rule out any off-target effect of MG132 on proteasome
inhibition, we also conducted experiments using another proteasome inhibitor, bortezomib (40), and a strain expressing a
temperature-sensitive allele of CIM3 (cim3–1) encoding a proteasome subunit (38). Fluorescent confocal microscopy of cells
co-cultured with bortezomib displayed virtually identical
results to those obtained using MG132. However, cells expressing CIM3–1 manifested Pca1p stabilization at the ER at both
permissive (23 °C) and restrictive (37 °C) temperature (data not
shown), which was confirmed by Western blotting analysis (Fig.
1F, fourth versus fifth lane). This indicates that Cim3–1p is not
VOLUME 291 • NUMBER 29 • JULY 15, 2016
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FIGURE 1. Localization of Pca1p at the membrane of the cells in which the proteasome or Cdc48p is inactivated. A, schematic of Pca1p. The black squares
indicate eight transmembrane helices. GFP or 3HA is fused at the N terminus (filled oval). 2Myc is fused at the C terminus (empty oval). The empty square indicates
the amino acid 250 –350 region containing a degron. B, subcellular distribution of Pca1p determined by fluorescent microscopy. Expression plasmids of
GFP-fused Pca1p and red fluorescent protein-fused Sec63p, an ER-resident protein, were co-expressed in a control strain lacking PDR5 (WT) and a strain
containing a temperature-sensitive allele of CDC48 (cdc48 –3). Mid-log phase cells were cultured with and without MG132 for 2 h. Cycloheximide was added to
the medium 1 h before collecting cells. The cdc48 –3 cells cultured at 23 °C were shifted to 37 °C for 30 min. Subcellular distribution of Pca1p-GFP was visualized
by confocal fluorescent microscopy. C, detection of Pca1p and its fragments by immunoblotting. Pca1p fused with 3HA and 2Myc was expressed in a WT, a
strain expressing the cdc48 –3 allele, and a doa10⌬ strain. WT and cdc48 –3 cells were precultured with MG132 for 2 h and at 37 °C for 30 min, respectively. Total
cell extracts prepared by glass bead disruption and Triton X-100 (1%) solubilization were subjected to Western blotting using anti-HA and anti-myc antibodies.
The blots were also probed with anti-Pgk1p antibodies to determine equal loading. D, determination of the subcellular distribution of Pca1p. Lysates of the cells
that were cultured as described in C were prepared by glass bead disruption, followed by removing unbroken cells (centrifugation at 300 ⫻ g for 10 min). The
samples were separated to soluble and pellet fractions by centrifugation (100,000 ⫻ g for 30 min). The S and P fractions were solubilized (1% Triton X-100) and
subjected to Western blotting analysis using anti-HA antibodies. E, detection of the majority of ubiquitinated Pca1p at the P fraction. Pca1p in the S and P
fractions obtained from WT cells as described above was immunoprecipitated using anti-HA antibodies. The expression levels and ubiquitination status of
Pca1p were determined by Western blotting using anti-HA and anti-Ub antibodies, respectively. F and G, the experiments presented in C and D were conducted
using bortezomib, a proteasome inhibitor, and a strain carrying a temperature-sensitive cim3–1 allele. The arrowheads (C–G), asterisks (C, F, and G), and arrows
(C and F) indicate the location of full-length non-ubiquitinated Pca1p, nonspecific bands detected by anti-myc (C) or anti-HA (F) antibodies, and a Pca1p
fragment dominant in proteasome-inactive WT cells relative to other cells, respectively. Each experiment was conducted three or more times using different
clones, and representative data are presented.

fully functional at both 23 °C and 30 °C. Fractionation of soluble
and membrane proteins followed by Western blotting of Pca1p
also displayed similar results in bortezomib and MG132 co-cultures (Fig. 1G). Collectively, the data presented in Fig. 1 suggests that most of Pca1p and its fragments, except for an ⬃60JULY 15, 2016 • VOLUME 291 • NUMBER 29

kDa fragment, are not dislodged from the membrane without
the activities of the proteasome and Cdc48p.
Pca1p in the Pellet Fraction Exists as Membrane-integrated
Species—We next considered the possibilities that Pca1p could
be extracted out of the lipid bilayer but attached to the memJOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 2. Detection of fragmented or ubiquitinated Pca1p by subcellular
fractionation. A, the majority of Pca1p and its fragments are embedded in
the membrane. Pca1p fused with triple HA at the N terminus was expressed in
a control strain lacking PDR5 (WT), a strain expressing a cdc48 –3 temperaturesensitive allele, and a doa10⌬ strain. WT and cdc48 –3 cells were cultured with
MG132 (20 M, 2 h) and at 37 °C (30 min), respectively. Membrane fractions
obtained by centrifugation (100,000 ⫻ g, 30 min) of the total cell lysate were
resuspended in PBS with and without Na2CO3 (0.2 M, pH 11) or Triton X-100
(1%). The samples were incubated for 30 min on ice and then centrifuged at
100,000 ⫻ g for 30 min. The supernatant was precipitated in trichloroacetic
acid (10%) and washed twice with acetone. The nonsoluble pellet was resuspended in PBS containing detergent (1% Triton X-100). Samples were denatured in SDS sample buffer (37 °C, 15 min) and analyzed by Western blotting
using anti-HA antibodies. B, fractionation of Pca1p by flotation sucrose gradient. WT cells expressing 3HA-tagged Pca1p or Pca1p(degron⌬) lacking the
first 392 amino acids containing a degron were co-cultured with MG132 for
2 h. Cycloheximide was added to the medium 1 h before collecting cells. Total
cell lysates were prepared by glass bead disruption followed by centrifugation (300 ⫻ g, 10 min) to remove unbroken cells. Samples were loaded at the
layer of 1.7 M sucrose density at a 0.25–2.3 M gradient from top to bottom. After
centrifugation (100,000 ⫻ g, 5 h), the collected fractions were subjected to
Western blotting. An aliquot was incubated with Triton X-100 (1%) on ice for
30 min before the fractionation to extract Pca1p out of the membrane.
Obtained fractions were subjected to Western blotting analyses of Pca1p and
Pca1p(degron⌬) using anti-HA antibodies. Pgk1p was detected as a marker of
fractions containing soluble proteins. C, distribution of full-length, ubiquitinated, and fragmented Pca1p species. Fractions obtained as described in B
were subjected to Western blotting analysis of Pca1p with and without treatment of deubiquitination enzyme. Fractions 10, 11, and 12 containing cytosolic proteins were pooled, deubiquitinated (De-Ub), and then solubilized by
detergent (1% Triton X-100). Pca1p was immunoprecipitated using anti-HA
antibodies. The samples were subjected to Western blotting using anti-Ub
and anti-HA antibodies. The arrowhead indicates the location where fulllength non-ubiquitinated Pca1p migrates. Results were confirmed by three or
more repeats, and representative data are presented.

brane or form large cytosolic complexes that could be pulled
down to the pellet fraction. To address these concerns, the
membrane fractions were incubated with Na2CO3 (0.2 M, pH
11) (48) to release peripheral membrane proteins to the supernatant (S, Fig. 2A). However, all Pca1p species, including Pca1p
fragments that migrate faster than full-length Pca1p, remained
in the non-soluble pellet (N) factions of WT cells co-cultured
with MG132 (Fig. 2A, left panel). Na2CO3 dissociates only a
small potion (⬍5%) of full-length and fragmented Pca1p from
the membrane (Fig. 2A, left panel, third lane). Only a small
portion of Pca1p detected in the membrane fraction was disso-
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ciated by Na2CO3 in Cdc48p-inactive cells and in doa10⌬ cells
(Fig. 2A, center and right panels), indicating membrane integration of Pca1p species. Triton X-100 (1%, v/v) released Pca1p to
the S fraction nearly completely (Fig. 2A), suggesting that most
Pca1p and its fragments are integrated in the membrane.
To confirm the localization of Pca1p in the membrane rather
than aggregated complexes, cell lysates were subjected to
sucrose density gradient fractionation (45) (Fig. 2B). If Pca1p is
in membrane vesicles, it will “float” to the low-density fractions.
WT cells expressing 3HA-tagged Pca1p or Pca1p(degron⌬)
lacking the first 392 amino acids containing the degron were
co-cultured with MG132 for 2 h. Glass bead-disrupted cells
were loaded at the layer of 1.7 M sucrose. Centrifugation followed by Western blotting analysis of collected fractions
showed that the majority of full-length Pca1p and Pca1p(⌬392)
were within the membrane-containing low-density fractions,
unlike Pgk1p, a soluble protein (Fig. 2B, fourth panel). Membrane solubilization of cell lysate with Triton X-100 (1%, v/v)
resulted in co-fractionation of Pca1p with Pgk1p (Fig. 2B, third
panel).
Pca1p species with different degrees of ubiquitination may
exist in the cytosol below the detectable limit by Western blotting. To address this concern, we assessed the ubiquitination
status of Pca1p in fractions 10, 11, and 12 containing soluble
proteins. Pca1p was immunoprecipitated using anti-HA antibodies and then probed with antibodies against ubiquitin and
HA epitopes (Fig. 2C). The soluble protein fractions contained
three major ubiquitin-conjugated Pca1p fragments (⬃60, ⬃75,
and ⬃90 kDa) (Fig. 2C, first panel). It was further determined
that poly-ubiquitinated full-length Pca1p species were not
present in the soluble fractions because deubiquitination by the
purified catalytic subunit of the deubiquitinating enzyme,
USP2, did not lead to an enrichment of full-length Pca1p (Fig.
2C, second panel). Anti-HA antibodies detected primarily a
fragment of ⬃60 kDa. Given the predicted N-terminal cytosolic
domain (61 ⫹ ⬃3 kDa corresponding to tagged 3HA epitopes),
the ubiquitinated Pca1p fragment detected in the soluble fraction could be a cleaved N-terminal cytosolic domain. However,
a portion of the fragment was also detected in the membrane
fraction as a peptide integrated into the membrane (Figs. 1, D
and G, and 2, A and B). Therefore, it is likely that the fragment
contains one or more transmembrane helices (Fig. 1A) and/or
domain(s) incorporated into the lipid bilayer. Collectively,
these results indicate that, in the absence of proteasomal activities, Pca1p and most of its fragments, except for the ⬃60-kDa
fragment, are not dislodged from the membrane.
Pca1p Interacts with the Proteasome at the ER Membrane in
an E3 Ligase- and Degron-dependent Manner—Given the
potential role for the proteasome in extraction of Pca1p from
the ER, we next determined whether the proteasome forms a
complex with Pca1p at the ER membrane. WT and doa10⌬ cells
expressing C-terminal two c-myc epitope-tagged wild-type
control Pca1p and Pca1p lacking the N-terminal 392 amino
acids that contain a degron (Pca1(degron⌬)) were co-cultured
with MG132 to inactivate the 20S proteasome. Membrane fractions were isolated as described in Fig. 1D, washed, and solubilized (Triton X-100, 1% (v/v)). Samples were then subjected to
immunoprecipitation of Pca1p. The formation of a complex
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FIGURE 3. Pca1p forms a complex with the proteasome at the membrane in a Doa10p-dependent manner. Pca1p, Pca1p(degron⌬) deleting the first 392
amino acids, and control empty vector were expressed in WT and doa10⌬ strains. Two c-myc epitopes were tagged at the C terminus of Pca1p. Cells were
cultured with and without a cell-permeable and reversible cross-linker (DTBP, 100 g/ml) and MG132 (20 M) for 2 h. Cell lysates were obtained by Triton X-100
(1%) solubilization of the membrane fraction. A, C, and D, the samples were subjected to immunoprecipitation using anti-myc antibodies. Co-immunoprecipitation of Pca1p with Rpn5p, a subunit of the 19S regulatory particle (A and C), and the ␣ and ␤ subunits of the 20S catalytic core (D) was determined by Western
blotting. B, Pcalp and Rpn5 levels in the input (cell lysate) and flow-through of Pca1p immunoprecipitation (IP flow-through) were compared by Western
blotting. Each experiment was conducted twice using two independent clones, and representative data are presented.

between Pca1p and Rpn5, a proteasome subunit (49), was visualized by Western blotting. However, no detectable association
was observed without cross-linker co-culture (Fig. 3A, lane 3).
This could reflect a transient binding between Pca1p and the
proteasome in the process of degradation. To address this concern, we conducted the experiment using a membrane-permeable thiol-reversible cross-linker, DTBP. After breaking the
cross-links by denaturing samples in dithiothreitol-containing
SDS sample buffer, the physical interactions of the proteasome
subunits (39) with Pca1p were visualized by Western blotting.
Indeed, Pca1p was found to form a complex with Rpn5p, a 19S
proteasomal subunit (Fig. 3, A, fourth lane, and C, second lane),
and the ␣ and ␤ subunits of 20S the proteasome (Fig. 3D) at the
membrane. Although the immunoprecipitation efficiency of
Pca1p was over 90% (Fig. 3B, top panel, second versus fourth
lane), most Rpn5p (⬎81%) still remained in the flow-through
(Fig. 3B, center panel, second versus fourth lane). This suggests
that Rpn5p is associated not only with Pca1p but also with other
membrane proteins.
The complex formation between Pca1p and Rpn5p was dependent on Doa10p and the degron in Pca1p (Fig. 3C).
Although the expression levels of Pca1p in doa10⌬ cells and
Pca1p lacking the degron (Pca1p(degron⌬)) were strikingly
higher than Pca1p levels in wild-type control cells (Fig. 3C,
third lane) (34, 35), immunoprecipitation of Pca1p and
Pca1p(degron⌬) in doa10⌬ and WT cells, respectively, did not
pull down Rpn5p at detectable levels (Fig. 3C, second panel).
These results confirm the specificity in complex formation
JULY 15, 2016 • VOLUME 291 • NUMBER 29

between Pca1p and Rpn5p and indicate that, when Pca1p is
ubiquitinated by Doa10p, the proteasome is recruited while
Pca1p resides at the membrane.
Cdc48p Is Required for Complex Formation between Pca1p
and the Proteasome—Cdc48p is a critical molecular factor for
ERAD of Pca1p (Figs. 1, 2A, and 4A) and other proteins (10, 34,
37). The ATPase activities of Cdc48p are believed to contribute
to the retrotranslocation of ubiquitinated luminal proteins for
ERAD (37), and Cdc48p may escort them to the proteasome, as
demonstrated by a physical interaction between Cdc48p and
the proteasome (37). To determine the role of Cdc48p in the
ERAD of Pca1p in conjunction with the interaction between
Pca1p and the proteasome, we ascertained whether the proteasome forms a complex with Pca1p in cells expressing inactive
Cdc48p. The levels of ubiquitinated proteins in cells expressing
non-functional Cdc48p (37 °C culture) are comparable (1.26- ⫾
0.62-fold, n ⫽ 3, p ⫽ 0.53) with those of control (23 °C culture)
cells (Fig. 4A, first panel). Despite higher Pca1p expression in
Cdc48p-defective cells (Fig. 4A, second panel), immunoprecipitation of Pca1p followed by Rpn5p detection revealed that formation of a complex between Pca1p and the proteasome is dramatically reduced in cells expressing non-functional Cdc48p
(Fig. 4B). This result suggests that Cdc48p recognizes ubiquitinated Pca1p for recruitment to the proteasome.
It was known that Cdc48p also interacts with other molecular factors involved in ERAD, such as the E4 ubiquitin chain
extension enzyme (50). The observed defect of Pca1p ERAD
(Fig. 1B) and the lack of Pca1p interaction with the proteasome
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 4. Cdc48p plays a role in Pca1p complex formation with the proteasome but not its poly-ubiquitination. A, no significant change of protein poly-ubiquitination in cells expressing non-functional Ccd48p. Pca1p
tagged with the triple HA epitope was expressed in a strain carrying temperature-sensitive cdc48 –3. Cells at mid-log phase were cultured at a permissive
temperature (23 °C) or shifted to a restrictive temperature (37 °C) for 30 min
with a cell-permeable and reversible cross-linker (DTBP, 100 g/ml) and
MG132 (20 M), a proteasome inhibitor, for 2 h. Membrane fractions were
solubilized with Triton X-100 (1%). The expression levels of Pca1p and Rpn5p
and the overall ubiquitination status were determined by Western blotting. B,
Cdc48p-dependent physical association between Pca1p and Rpn5p, a subunit of the 19S regulatory particle, was determined by co-immunoprecipitation. The Triton X-100 (1%)-solubilized membrane fraction was used for
immunoprecipitation of Pca1p using anti-HA antibodies. Co-immunoprecipitation of Rpn5p, a subunit of the 19S regulatory particle, was detected by
Western blotting. C, poly-ubiquitination of Pca1p as a function of Cdc48p
activities. To determine the ubiquitination status of Pca1p, the samples
obtained as described in B were subjected to Western blotting using antiubiquitin antibodies. To compare the relative ubiquitination of Pca1p, a
5-fold amount of immunoprecipitated Pca1p from cells cultured at 23 °C relative to those at 37 °C was loaded. Data were confirmed by triplicate
experiments.

(Fig. 4B) in cells expressing non-functional Cdc48p may be
attributed to a deficiency in recruiting E4 ligase(s) and/or presenting monoubiquitinated Pca1p for poly-ubiquitination. To
address this, we determined the ubiquitination status of Pca1p
in Cdc48p-inactive cells. Immunoprecipitation of Pca1p using
anti-HA antibodies followed by Western blotting analysis of
Pca1p using anti-ubiquitin antibodies determined poly-ubiquitination of Pca1p in cells expressing non-functional Cdc48p
(Fig. 4C). Given that Pca1p levels in cells expressing nonfunctional Cdc48p are 5-fold higher relative to those in control cells
(Fig. 4, A and B), for the experiment presented in Fig. 4C, we
loaded a 5-fold higher immunoprecipitated sample obtained
from cells cultured at 23 °C. Our data showed that cells expressing non-functional Cdc48p accumulate poly-ubiquitinated
Pca1p comparable with control cells (Fig. 4C). Therefore, the
higher Pca1p expression (Fig. 4A, second panel) and the
reduced association of Pca1p with the proteasome (Fig. 4B) in
Cdc48p-inactive cells are not likely attributable to a defect in
poly-ubiquitination of Pca1p.
Ufd2p, an E4 Ubiquitin Extension Enzyme for Pca1p, and
Poly-ubiquitination of Pca1p Did Not Affect Complex Formation between Pca1p and the Proteasome—Following ubiquitination by E3 ligase(s), E4 ubiquitin chain extension enzymes such
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FIGURE 5. Formation of a complex between Pca1p and the proteasome is
independent of poly-ubiquitination of Pca1p. A, significant reduction of
turnover rate of Pca1p in UFD2 gene knockout (ufd2⌬) cells. Pca1p tagged
with the two c-myc epitope at the C terminus was expressed in WT, ufd2⌬,
and hul5⌬ strains. Cycloheximide (CHX) chase and Western blotting determined Pca1p levels. Protein extracts were prepared by glass bead disruption
and detergent (1% Triton X-100) solubilization. Pgk1p was probed to determine equal loading. B, the Pca1p levels presented in A were quantitated (n ⫽
4). Pca1p levels relative to those at time 0 are presented. *, p ⬍ 0.01. C, defect
in poly-ubiquitination of Pca1p in an ufd2⌬ strain. The Pca1p-tagged c-myc
epitope was expressed in an ufd2⌬ strain. Total cell lysates were obtained
with and without co-culture with MG132 (20 M, 2 h). Samples were subjected
to separation to soluble and pellet fractions by centrifugation (100,000 ⫻ g
for 30 min). After solubilization with Triton X-100 (1%), the S and P fractions
were subjected to immunoprecipitation using anti-myc antibodies, followed
by Western blotting using anti-Ub and anti-myc antibodies to detect Pca1p.
D, distribution of Pca1p species in the S and P fractions in ufd2⌬ cells. Total cell
lysates (T) and the soluble and pellet fractions described in C were subjected
to Western blotting using anti-myc and -Pgk1p antibodies. E, formation of a
complex between Pca1p and Rpn5p, a subunit of the 19S proteasome. After
co-culturing the cells with a permeable and reversible cross-linker (DTBP, 100
g/ml) and MG132, an inhibitor of proteasomal proteolytic activities, cell
lysates were obtained by glass bead disruption and detergent solubilization.
The samples were subjected to immunoprecipitation using anti-myc antibodies. Rpn5p in the samples was detected by Western blotting using antiRpn5p antibodies. The arrowheads (C and D) indicate the location where fulllength Pca1p migrates. The experiment (B–D) was conducted twice using two
independent clones, and representative data are presented.

as Ufd2p and Hul5p in yeast have been implicated in the degradation of several ERAD substrates (10, 32, 50, 51). Ufd2p
interacts with Cdc48p and Rad23p in the process of substrate
delivery to the proteasome (28). It is intriguing that Ufd2p regulates turnover of only a subset of Doa10p substrates (33), and
Hul5p has been found to be associated with the 19S proteasome
(32, 52, 53). We determined the t1⁄2, poly-ubiquitination of
Pca1p, and formation of a complex between Pca1p and the proteasome in ufd2⌬ and hul5⌬ strains. Cycloheximide chase of
Pca1p revealed no significant difference in Pca1p degradation
in WT and hul5⌬ cells; however, UFD2 deletion dramatically
extended the t1⁄2 of Pca1p (Fig. 5, A and B). This result suggests
that Ufd2p is required for efficient turnover of Pca1p. Immunoprecipitation of Pca1p followed by immunoblotting using
anti-ubiquitin antibodies supported that Ufd2p is the major E4
VOLUME 291 • NUMBER 29 • JULY 15, 2016
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enzyme of Pca1p (Fig. 5C). In ufd2⌬ cells, most Pca1p species
were detected at the membrane fraction but not at the soluble
fraction (Fig. 5D), indicating that, in ufd2⌬ cells, the majority of
Pca1p remains in the membrane.
Because Ufd2p is required for efficient degradation of Pca1p
(Fig. 5B), we next sought to determine whether poly-ubiquitination by Ufd2p is necessary for the interaction of Pca1p with
the proteasome. In vivo cross-linking and co-immunoprecipitation followed by Western blotting analysis showed that Pca1p
is still able to interact with the proteasome in the absence of
Ufd2p (Fig. 5E). This indicates that Ufd2p-dependent ubiquitin
chain extension (Fig. 5C) is not critical for the formation of a
complex between Pca1p and the proteasome. This result also
further confirmed that the reduced interaction of Pca1p with
the proteasome in cells expressing nonfunctional Cdc48p (Fig.
4, B and C) is not relevant to the poly-ubiquitination status of
Pca1p.
Proteasome-dependent Extraction of ERAD Substrates Is Specific for Polytopic Proteins—We next determined whether other
polytopic membrane proteins undergoing ERAD manifest an
interaction with the proteasome at the membrane as observed
for Pca1p. Ste6*p is a mutated form of the ␣ factor transporter
Ste6p in yeast (54), which causes a premature stop codon and a
change in N-glycosylation. Ste6*p is also targeted for degradation via Doa10p, Cdc48p, and a proteasome-dependent pathway (10, 54, 55). Subcellular fractionation and flotation sucrose
gradient fractionation showed that Ste6*p remained in the
membrane fraction under proteasome inhibition conditions
(data not shown), as observed for Pca1p. The same experiment
described in Fig. 3A showed that Ste6*p pulled down a proteasome subunit, Rpn5p, in a Doa10p-dependendent manner (Fig.
6A). Therefore, Ste6*p also interacts with the proteasome at the
ER membrane when it is ubiquitinated by Doa10p.
The expression of Hmg2p, an ER-resident membrane
enzyme required for cholesterol synthesis, is controlled
through the ERAD-M pathway. When the proteasome is inactivated by MG132 co-culture, Hmg2p also forms a complex
with the proteasome at the membrane and not in the cytosol
(Fig. 6B). Therefore, as observed for Pca1p and Ste6*p, inhibition of the proteolytic function of the proteasome prevents
Hmg2p release from the ER membrane.
Vacuolar carboxypeptidase Y (Cpy1p) containing a G255R
mutation (Cpy1*p) is degraded through the ERAD-C pathway
(13, 56 –59). We have employed Cpy1*p as an example of an ER
luminal protein to elaborate the hypothesis that soluble ERAD
substrates may be retrotranslocated prior to being targeted
to the proteasome. When WT yeast cells expressing c-myc
epitope-tagged Cpy1*p were co-cultured with MG132, a proteasome inhibitor, Cpy1*p was detected as full-length and polyubiquitinated forms in the soluble fraction (Fig. 6C). Rpn5p, a
subunit of the 19S proteasome, was co-immunoprecipitated
with Cpy1*p in the soluble fraction (Fig. 6C, second panel), indicating that Cpy1*p forms a complex with the proteasome in the
cytosol. However, Cpy1*p in cells lacking Hrd1p E3 ligase targeting Cpy1*p for ERAD remains at the pellet fraction along
with Kar2p, an ER-luminal protein (Fig. 6D). Therefore, detection of Cpy1*p in the soluble fraction (Fig. 6C) is a consequence
of ERAD progress of Cpy1*p rather than its leaking from the ER
JULY 15, 2016 • VOLUME 291 • NUMBER 29

FIGURE 6. Ste6*p, Hmg2p, and Cpy1*p form a complex with the proteasome at the membrane. Ste6*p, Hmg2p, or Cpy1*p tagged with either HA or
the c-myc epitope was expressed in WT control (A–C) doa10⌬ (A) and hrd1⌬
(D) cells. Cells were co-cultured with MG132 (20 M, 2 h), an inhibitor of proteasomal proteolytic activities, and a cell-permeable reversible cross-linker
(DTBP, 100 g/ml, 30 min). Total cell lysates (T) were prepared by glass bead
disruption. Samples were subjected to separation of soluble and membrane
(P) fractions by centrifugation (100,000 ⫻ g, 30 min). Protein extracts were
obtained by solubilizing samples with detergent (1% Triton X-100). A, the
membrane fractions were used to determine an interaction of Ste6*p with
the proteasome. HA-Ste6*p was subjected to anti-HA immunoprecipitation
followed by Western blotting using anti-HA and anti-Rpn5 antibodies. B and
C, lysates of WT cells expressing Hmg2p-myc or Cpy1*p-myc were subjected
to fractionation (S and P) followed by detergent solubilization. Anti-myc
immunoprecipitation and Western blotting using anti-Rpn5p and anti-myc
antibodies determined their physical interaction. The ubiquitination status
was determined by probing the blots with anti-Ub antibodies (C, third panel).
D, Cpy1*p expressed in total cell lysate (T) and S and P fractions of hrd1⌬ cells
was detected by Western blotting using anti-myc antibodies. The blots were
also probed with antibodies against Kar2p and Pgk1p, an ER-resident protein,
and cytosolic protein, respectively. Representative data of two or more independent experiments are presented.

during sample preparation followed by interaction with the
proteasome. These results suggest that Cpy1*p ubiquitinated
by Hrd1p is retrotranslocated to the cytosol without proteolytic
activities of the proteasome. This is distinct from other examined polytopic proteins (Pca1p, Ste6*p, and Hmg2p).

Discussion
ERAD involves retrotranslocation of ER luminal proteins
and dislodging of membrane proteins. Our data suggest that
polytopic ERAD substrates undergo proteasomal degradation
at the ER membrane via recruiting the proteasome rather than
being extracted to the cytosol prior to delivery to the proteasome. This is distinct from ERAD of Cpy1*p, a soluble protein
in the lumen of the ER. The coupling of dislodging and destruction of membrane proteins would be advantageous for cells by
minimizing the energy cost associated with preventing detrimental effects of hydrophobic proteins in the cytosol. These
results shed new light on this vital but undercharacterized
process.
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Cdc48p (p97/VCP in higher eukaryotes), a hexameric AAAtype ATPase, plays diverse roles in ERAD (60, 61), although the
mechanistic details remain to be defined. Despite experimental
evidence arguing for a non-essential role of Cdc48p in the
ERAD process (62), our study confirmed that Cdc48p is a significant player for ERAD of Pca1p by promoting its binding to
the proteasome. In cells expressing inactive Cdc48p, the complex formation between the proteasome and Pca1p and Pca1p
degradation is impaired. This result is consistent with a previous report displaying cooperation between Cdc48p and the
proteasome in turnover of Insig-1p, an ERAD-M substrate (63).
Several lines of evidence support that Cdc48p and its cofactors
Ufd1p and Npl4p are recruited to the ER via Ubx2p to disassemble ubiquitin-conjugated substrates from the membrane
and for the delivery of those to the proteasome (60, 61). Therefore, it is likely that Cdc48p facilitates the interaction between
ubiquitinated Pca1p and the proteasome.
Distinct from the ERAD-L pathway dealing with soluble substrates, a concern in ERAD of integral membrane proteins
(ERAD-M and -C pathways) would be the extraction of proteins from the lipid bilayer and solubilization at the cytosol (10,
64). Although several potential mechanisms have been proposed (3, 10, 32), the results reported previously were not consistent with each other. An in vitro reconstitution assay found
that, prior to degradation, Ste6*p, a well characterized ERAD-C
substrate, is dislodged from the membrane (10). However, it is
worth pointing out that only a small fraction of Ste6*p was
released from the membrane under the experimental conditions. Secondly, an in vitro ERAD assay of cystic fibrosis transmembrane conductance regulator (CFTR) displayed relatively
minor effects of proteasome inactivation on extraction and
release of its degradation intermediates from the ER membrane
(65). Our study was conducted in cells, and most ubiquitinated
Pca1p and its fragments remained in the membrane and formed
a complex with the proteasome. This finding was confirmed
with two other polytopic proteins. Therefore, our data support
the hypothesis that dislodging of membrane proteins does not
occur prior to their delivery to the proteasome.
Detection of the complex containing Pca1p and subunits of
the 19S and 20S proteasomes from the membrane fractions is
dependent on Doa10p, the major E3 ubiquitin ligase of Pca1p.
This suggests that ubiquitinated Pca1p attracts the proteasome
while residing in the ER membrane. The proteasomes are localized mainly in the nucleus and cytosol as free or nuclear envelope- and ER network-attached forms (66 – 69). The clustering
of the proteasomes on the ER membrane is particularly high in
the yeast S. cerevisiae (⬎80% total proteasome) relative to
mammals (⬍20%) (67). The proteasome might be associated
with the ER via physical interaction with ER membrane protein(s), which is reminiscent of Cue1 and Ubx2p recruiting
Ubc6p/7p and Cdc48p to the ER membrane, respectively (71–
73). This may allow for rapid recognition of ERAD substrates by
the proteasome. Sts1p is critical for enriching the proteasome at
the nuclear envelope (70). However, the counterpart at the ER
membrane remains to be identified. Alternatively, the enrichment of the proteasome at the ER membrane might reflect the
complexes between the proteasome and proteins undergoing
ERAD. High demand of ERAD might control the distribution of
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the proteasomes for an efficient completion of the task. The
26S, 20S, and 19S proteasomal particles are known to exist in a
dynamic equilibrium (68). The assembly, subunit composition,
posttranslational modifications of amino acid residues, and
interaction of the proteasome with regulators(s), if any, could
be changed in response to cellular cues and stresses (66). It
would be interesting to examine whether ER stresses would
lead to an enrichment of the proteasomes to the ER membrane.
This could be better accessed in mammals displaying relatively
minor steady-state ER localization of the proteasome (74, 75).
The significance of poly-ubiquitination of membrane proteins in ERAD remains an intriguing question. The regulatory
particles of the proteasome contain several functional components, including AAA-type ATPase, E4 ubiquitin ligase(s), and
deubiquitination enzyme(s). Hul5p, an E4 enzyme associated
with the regulatory particle of yeast, is involved in ERAD of
reporter substrates (e.g. CTL* and Sec61–2L) (32) and proteasome-dependent degradation of cytosolic proteins that are
damaged under heat stress (52). However, knockout of the
UFD2 gene encoding another E4 ligase did not affect the heatinduced ubiquitination (52). Our study on the turnover rate of
Pca1p in the hul5⌬ and ufd2⌬ strains showed that Ufd2p, but
not Hul5p, is involved in ERAD of Pca1p, confirming the target
specificity of E4 ligases. Nevertheless, it is worth noting that the
relative stability of Pca1p in the ufd2⌬ strain was still significantly lower than that of the doa10⌬ strain (t1⁄2 ⫽ 30 min versus
⬎2 h), which suggests that poly-ubiquitination is not essential
for ERAD but enhances efficiency. One might argue that, given
three other E4 ligases in addition to Hul5p and Ufd2p in the
genome of the yeast S. cerevisiae (76), there may be some redundancy. However, we disproved this by showing a near absence
of poly-ubiquitinated Pca1p in ufd2⌬ cells. It is also interesting
to note that, although Pca1p turnover is slow in ufd2⌬ cells and
a drastic reduction of poly-ubiquitination of Pca1p in the cells,
Ufd2p deficiency does not affect the formation of a complex
between Pca1p and the proteasome. These results indicate that
poly-ubiquitination of Pca1p is not a critical determinant of the
initial interaction with the proteasome but, rather, promotes
efficient processing of substrates by the proteasome.
This study reflects a comprehensive in vivo study determining how polytopic proteins are targeted to the ERAD pathway in
yeast. The recruitment of the proteasome to ubiquitinated proteins while they reside in the membrane could be a conserved
mechanism in ERAD of higher eukaryotes. It would be also
interesting to define whether the proteasome-dependent
destruction of membrane proteins in other organelles occurs in
a similar manner.
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